Pharmaceuticals by operating margin
Operating income as a share of revenue for the latest fiscal year: what the business keeps of each dollar of sales before interest and tax. Banks, insurers and other companies that report no operating income are not ranked.
Royalty Pharma leads the 43 pharmaceuticals ranked by operating margin, at 65.6%, ahead of PTC Therapeutics (50.1%) and United Therapeutics (46.9%). Figures as of 18 Nov 2026, 14:10 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 43
- First
- Royalty Pharma65.6%
- Median
- 12.5%
- Combined market value
- NOK 49.96T
- Countries
- 10
- Not ranked
- 18no operating margin on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Operating margin ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Royalty PharmaRPRX · Health Care | 65.6% | NOK 382.5B | NOK 665.20 | 0.23% up | 78% up | ||
| 2 | PTC TherapeuticsPTCT · Health Care | 50.1% | NOK 48.8B | NOK 584.62 | 1.00% down | 20% down | ||
| 3 | United TherapeuticsUTHR · Health Care | 46.9% | NOK 240.9B | NOK 5,657.29 | 0.64% down | 23% up | ||
| 4 | Novo NordiskNVO · Health Care | 41.3% | NOK 1.74T | NOK 394.20 | 2.16% down | 17% down | ||
| 5 | Vertex PharmaceuticalsVRTX · Health Care | 34.8% | NOK 1.31T | NOK 5,173.99 | 0.67% down | 27% up | ||
| 6 | NovartisNVS · Health Care | 32.4% | NOK 2.91T | NOK 1,541.25 | 0.67% down | 25% up | ||
| 7 | GenmabGMAB · Health Care | 28.6% | NOK 310.3B | NOK 503.26 | 0.76% up | 70% up | ||
| 8 | Regeneron PharmaceuticalsREGN · Health Care | 24.9% | NOK 959.6B | NOK 9,276.37 | 0.56% up | 36% up | ||
| 9 | AbbVieABBV · Health Care | 24.6% | NOK 5.01T | NOK 2,836.11 | 0.59% down | 26% up | ||
| 10 | GSKGSK · Health Care | 24.3% | NOK 956B | NOK 476.91 | 2.32% down | 6% up | ||
| 11 | AstraZenecaAZN · Health Care | 23.4% | NOK 2.74T | NOK 1,765.37 | 0.95% down | 2% up | ||
| 12 | TG TherapeuticsTGTX · Health Care | 20.0% | NOK 91.8B | NOK 607.38 | 0.08% down | 107% up | ||
| 13 | Abbott LaboratoriesABT · Health Care | 18.2% | NOK 1.76T | NOK 1,014.17 | 2.55% down | 17% down | ||
| 14 | AlkermesALKS · Health Care | 17.2% | NOK 74B | NOK 440.21 | 2.32% down | 58% up | ||
| 15 | GrifolsGRFS · Health Care | 16.5% | NOK 56.9B | NOK 83.59 | 1.15% down | 1% up | ||
| 16 | Ligand PharmaceuticalsLGND · Health Care | 15.3% | NOK 56.9B | NOK 2,845.69 | 2.62% down | 43% up | ||
| 17 | Dr. Reddy's LaboratoriesRDY · Health Care | 15.0% | NOK 119.4B | NOK 143.25 | 0.61% up | 5% up | ||
| 18 | SanofiSNY · Health Care | 14.5% | NOK 1.11T | NOK 460.35 | 1.78% down | 4% down | ||
| 19 | Alnylam PharmaceuticalsALNY · Health Care | 13.5% | NOK 203B | NOK 1,515.78 | 2.02% down | 66% down | ||
| 20 | Amneal PharmaceuticalsAMRX · Health Care | 13.1% | NOK 71.3B | NOK 204.56 | 0.52% down | 83% up | ||
| 21 | BioMarin PharmaceuticalBMRN · Health Care | 12.7% | NOK 109.8B | NOK 566.70 | 0.90% up | 11% up | ||
| 22 | Teva Pharmaceutical IndustriesTEVA · Health Care | 12.5% | NOK 481.7B | NOK 412.80 | 0.12% up | 74% up | ||
| 23 | Arrowhead PharmaceuticalsARWR · Health Care | 11.9% | NOK 58.9B | NOK 416.38 | 2.76% down | 10% up | ||
| 24 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 11.4% | NOK 72.4B | NOK 921.19 | 0.93% up | 126% up | ||
| 25 | BeOne MedicinesONC · Health Care | 8.37% | NOK 457.2B | NOK 4,002.63 | 0.48% up | 17% up | ||
| 26 | Corcept TherapeuticsCORT · Health Care | 5.88% | NOK 74.3B | NOK 678.66 | 1.23% up | 8% down | ||
| 27 | Takeda PharmaceuticalTAK · Health Care | 0.14% | NOK 669.6B | NOK 209.59 | 0.23% up | 54% up | ||
| 28 | Mirum PharmaceuticalsMIRM · Health Care | -4.25% | NOK 58.1B | NOK 890.58 | 0.40% up | 31% up | ||
| 29 | Jazz PharmaceuticalsJAZZ · Health Care | -10.1% | NOK 149.6B | NOK 2,331.39 | 0.39% up | 37% up | ||
| 30 | Travere TherapeuticsTVTX · Health Care | -12.8% | NOK 47.5B | NOK 494.93 | 2.82% up | 44% up | ||
| 31 | Legend BiotechLEGN · Health Care | -13.3% | NOK 30.3B | NOK 156.03 | 0.75% up | 42% down | ||
| 32 | ViatrisVTRS · Health Care | -18.6% | NOK 227.1B | NOK 198.07 | 1.40% down | 96% up | ||
| 33 | Ascendis PharmaASND · Health Care | -18.9% | NOK 172.3B | NOK 2,626.61 | 0.20% down | 28% up | ||
| 34 | Axsome TherapeuticsAXSM · Health Care | -26.1% | NOK 69.3B | NOK 1,316.74 | 0.77% down | 7% down | ||
| 35 | Madrigal PharmaceuticalsMDGL · Health Care | -31.3% | NOK 94.9B | NOK 4,087.18 | 0.46% down | 24% down | ||
| 36 | Ionis PharmaceuticalsIONS · Health Care | -40.4% | NOK 43.5B | NOK 261.12 | 3.75% down | 64% down | ||
| 37 | Rhythm PharmaceuticalsRYTM · Health Care | -101% | NOK 78.3B | NOK 1,129.42 | 8.49% up | 13% up | ||
| 38 | BridgeBio PharmaBBIO · Health Care | -104% | NOK 144.9B | NOK 743.85 | 0.72% down | 17% up | ||
| 39 | InsmedINSM · Health Care | -206% | NOK 258.9B | NOK 1,180.27 | 0.83% down | 40% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | -344% | NOK 78.8B | NOK 1,207.49 | 0.13% down | 46% up | ||
| 41 | CytokineticsCYTK · Health Care | -695% | NOK 69.7B | NOK 500.26 | 2.86% down | 20% down | ||
| 42 | Roivant SciencesROIV · Health Care | -6236% | NOK 271.7B | NOK 374.93 | 0.26% up | 90% up | ||
| 43 | Dianthus TherapeuticsDNTH · Health Care | -8739% | NOK 47.4B | NOK 842.44 | 2.87% down | 113% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Operating margin is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Banks and insurers report no operating income and are not ranked on it. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6855 NOK). 18 companies have no operating margin on file and are not ranked here.
Questions and answers
Which pharmaceuticals rank first by operating margin?
Royalty Pharma (65.6%), PTC Therapeutics (50.1%) and United Therapeutics (46.9%) are the top three of the 43 pharmaceuticals ranked by operating margin as of 18 Nov 2026, 14:10 UTC.
How many pharmaceuticals are in this ranking?
43 are ranked by operating margin. 18 more have no operating margin on file and are left out rather than ranked at zero.
What are these pharmaceuticals worth together?
The 43 pharmaceuticals ranked by operating margin have a combined market value of NOK 49.96T as of 18 Nov 2026, 14:10 UTC.
What does ranking by operating margin measure?
Operating income as a share of revenue for the latest fiscal year: what the business keeps of each dollar of sales before interest and tax. Banks, insurers and other companies that report no operating income are not ranked.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Pharmaceuticals by operating margin”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=operating-margin
Underlying data: Yahoo Finance; SEC EDGAR.